Pharmacokinetic Drug Interactions of AEGR-733 on Lipid-lowering Agents

NCT00359281 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
125
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Aegerion Pharmaceuticals, Inc.